Cellectis (CLLS) EBT (2015 - 2026)

Cellectis' EBT history runs 12 years deep, the most recent figure standing at -$8.8 million for Q1 2026.

• In Q1 2026, EBT fell 473.36% year-over-year to -$8.8 million; the TTM figure through Mar 2026 stood at -$8.8 million (down 473.36% YoY), while the FY2025 annual figure was -$68.0 million, down 85.02% from the prior year.
• EBT was -$8.8 million for Q1 2026 at Cellectis, up from -$108.1 million in the prior quarter.
• In the past five years, EBT ranged from a high of $34.4 million in Q3 2024 to a low of -$108.1 million in Q4 2025.
• Historically, EBT has averaged -$11.8 million across 5 years, with a median of -$7.3 million in 2023.
• The sharpest annual moves came in 2023 and 2024: EBT tumbled 3000.46% in 2023, then surged 493.1% in 2024.
• A 5-year view of EBT shows it stood at -$2.8 million in 2022, then sank by 3000.46% to -$88.0 million in 2023, then soared by 35.94% to -$56.3 million in 2024, then slumped by 91.81% to -$108.1 million in 2025, then jumped by 91.83% to -$8.8 million in 2026.
• The last three EBT figures came in at -$8.8 million (Q1 2026), -$108.1 million (Q4 2025), and $33.1 million (Q3 2025), per Business Quant data.